TRAVERE THERAPEUTICS, INC.: revenue

Value{"amount": 227490000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"}
Period2021-01-01 – 2021-12-31
Statussuperseded
EntityTRAVERE THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001438533-22-000008
Retrieved: 2026-08-19T14:10:36.228718+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001438533/revenue/2021-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/d923f75a-bdf5-4bfc-8569-bac11c492c51

History